Auswahl der wissenschaftlichen Literatur zum Thema „Sexual dysfunction, physiological – therapy“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Inhaltsverzeichnis
Machen Sie sich mit den Listen der aktuellen Artikel, Bücher, Dissertationen, Berichten und anderer wissenschaftlichen Quellen zum Thema "Sexual dysfunction, physiological – therapy" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Zeitschriftenartikel zum Thema "Sexual dysfunction, physiological – therapy"
1
Lukyantseva, G. V., und S. Y. Frank. „Possible applications of shock wave therapy in complex correction of sexual dysfunction in women“. HEALTH OF WOMAN, Nr. 9(135) (30.11.2018): 112–17. http://dx.doi.org/10.15574/hw.2018.135.112.
Der volle Inhalt der QuelleAnnotation:
In recent decades, interest in the quality of sexual life has significantly increased all over the world, not only among men but also among women, especially in low-birth-rate European countries. Improving this quality will not only resolve health issues in men and women, but will also improve the demographic situation in these countries. Scientific research in the field of both male and female sexual dysfunction is developing at a rapid pace. Both men and women go through the same phases of sexual reactions cycle: sexual desire, sexual arousal, and, as a result, orgasm and resolution phase. During the phase of sexual arousal, in both men and women, the blood flow to pelvic organs increases, but in the event of erectile dysfunction in men and frigidity in women, this process weakens or does not occur at all. Furthermore, the innervation of genital organs in male and female organisms is identical. Activation, which enables genital innervation, launches the activation of blood circulation in the target organs. Therefore, in case of ED in men, and in case of female sexual arousal disorder in women, along with other specific treatment methods, it is useful to perform non-invasive stimulation of insufficiently active physiological mechanisms of sexual arousal. However, for the treatment of ED in men, such stimulation has already been successfully used for a long time – that is the low-intensity extracorporeal shock wave therapy, which allows to restore the erection mechanism itself. Studies from throughout the world, including those conducted by Ukrainian scientists, have established that low-intensity extracorporeal shock wave therapy induces neovascularization and therefore improves blood circulation. The intensity of the basal and sexually stimulated genital blood flow is a necessary physiological tool of sexual arousal and orgasmic discharge, which makes the subject of artificial stimulation of this indicator by means of shock wave therapy in both men and women particularly important. The use of shock wave therapy can have a number of advantages not only due to the increased blood and lymph flow in the genitals, but also due to the powerful stimulation of the release of neurotransmitters and hormones which provide emotional coloring to the sexual feeling and increase libido (serotonin, dopamine, endorphins etc.). Therefore, along with combined therapy, the method of low-intensity extracorporeal shock wave therapy can be successfully used in the treatment of female sexual dysfunction. Key words: shock wave therapy, sexual dysfunction, female sexual arousal disorder, erectile dysfunction, DSM-5.
2
Bezkor, Mary F., und Angelo Canedo. „Physiological and psychological factors influencing sexual dysfunction in Multiple Sclerosis: Part 1“. Sexuality and Disability 8, Nr. 3 (September 1987): 143–46. http://dx.doi.org/10.1007/bf01376984.
Der volle Inhalt der Quelle
3
Starc, Andrej. „Clinical hypnosis and female sexual dysfunction“. Journal of applied health sciences 5, Nr. 1 (15.03.2019): 105–11. http://dx.doi.org/10.24141/1/5/1/10.
Der volle Inhalt der QuelleAnnotation:
Background: Female sexual function comprises variable and multi-layered conditions that incorporate complex interactions of physiological, psychological, and interpersonal components. Despite the progress in understanding the neurobiology of sexual response, the definition of normal sexual response in women remains unresolved. Normal female sexual function differs from individual to individual and depends on the culture, ideology, beliefs, and other factors. Methods: We used a case report, the purpose of which is to justify further investigation into the effectiveness of hypnosis for the treatment of cervical pain during penetration, as well as orgasm disorder. Results: An orgasm was reached by masturbation performed on her by her partner, but without an orgasm by penile-vaginal penetration. The frequency of sexual intercourse has increased (3-4 times/week) in comparison to prior to therapy (once/ 2 months). Orgasm does not occur by self- and by partner masturbation every time, but sporadically; however, more frequently than before therapy. Success has been achieved with the orgasm by penile-vaginal penetration. Conclusions: Hypnotherapy may be a promising co-intervention or intervention per se for both physical and psychological symptoms. The results of hypnotherapy demonstrate that symptoms were significantly alleviated and, consequently, the quality of life improved. Symptoms of pain during sexual intercourse were not eliminated, but the patient had achieved significant control over those symptoms.
4
Cohen, Seth D., Steven Mandel und David B. Samadi. „Assessing Sexual Dysfunction Part 2: Female Sexual Dysfunction“. Guides Newsletter 21, Nr. 3 (01.05.2016): 3–8. http://dx.doi.org/10.1001/amaguidesnewsletters.2016.mayjun01.
Der volle Inhalt der QuelleAnnotation:
Abstract Sexual dysfunction is more common in women (43%) than men (31%), and the evaluating physician must consider the individual's chronological and physiologic age, personal and interpersonal sexual experiences, life events, and relationship issues that may have an effect on female sexual health. The medical history should include focused questions about medical and/or surgical illnesses, use of medications, and urogynecological history. Validated, reliable, standardized questionnaires are useful to identify the presence or absence of various domains of female sexuality such as sexual desire, sexual arousal, orgasm, and/or sexual pain (eg, the Female Sexual Function Index). Serum hormone testing should be dictated by clinical suspicion, and the physician also may assess multiple androgen and estrogen values, as well as pituitary function and levels of thyroid stimulating hormone. Systemic androgens (eg, systemic dehydroepiandrosterone and/or systemic testosterone) may improve mood, energy, stimulation, sensation, arousal, and orgasm in women with sexual health concerns. Combining a biomedical and psychosocial approach to any kind of sexual dysfunction helps to optimize patient outcomes. In the case of hypoactive sexual desire disorder (HSDD), individual or couples-based therapy with a sexual health therapist should be part of the consultation. If the biologic basis of the sexual health concern can be diagnosed by history, physical examination, laboratory testing, and directed imaging studies, then management can be directed to evidence-based management strategies.
5
Khashukoeva, A. Z., M. V. Burdenko, A. V. Overko, T. E. Ryzhova und M. S. Safonina. „Disorders of sexual function in postmenopausal patients“. Meditsinskiy sovet = Medical Council, Nr. 3 (15.04.2021): 106–11. http://dx.doi.org/10.21518/2079-701x-2021-3-106-111.
Der volle Inhalt der QuelleAnnotation:
Introduction. Research in recent years has shown that sexual dysfunction is now common in post-menopausal women and that it has a significant impact on their quality of life.Aim: to identify the major causes of sexual dysfunction in postmenopausal women and their treatment options, by analysing different literature sources.Materials and methods. During the study of this problem, 25 sources of literature, both Russian and foreign, dating from 2007 to 2020 were analysed.Results and discussion. The main etiological aspects of sexual dysfunction in postmenopausal women, such as disorders of sexual desire, sexual pain disorders, orgasmic disorders are considered in this article. The role of physiological processes occurring in a woman’s organism during this age period in the formation of sexual dysfunction is presented, namely, the influence of insufficiency of sex hormones (In particular, estrogens) and genitourinary syndrome on disorders of the sexual sphere.The main methods of treatment are described, including hormone replacement therapy, the use of non-invasive laser technology, and surgical correction of the dysfunction and atrophy of the pelvic floor muscles. Particular attention is paid to the use of the synthetic steroid tibolone and flibanserin, a drug used to treat hypoactive sexual desire disorder, and the data concerning their high efficacy are presented.Conclusions. The predominant manifestation of sexual dysfunction are disorders of sexual desire and sexual pain disorders. Thus it is important to pay attention to this problem and to treat sexual dysfunction by treating its causes.Conclusion. The treatment of sexual dysfunction must address the causes. In many cases, psychotherapy is necessary. MHT has a positive effect on the sexual function of patients. Testosterone therapy is justified in this case, but is rarely used, as it has a number of side effects and contraindications. Synthetic steroids (Tibolone) have shown good results in the treatment of sexual dysfunction.
6
Salehpour, Farzad, Mahsa Khademi, Farzan Vahedifard und Paolo Cassano. „Transcranial Photobiomodulation Therapy for Sexual Dysfunction Associated with Depression or Induced by Antidepressant Medications“. Photonics 9, Nr. 5 (11.05.2022): 330. http://dx.doi.org/10.3390/photonics9050330.
Der volle Inhalt der QuelleAnnotation:
Sexual dysfunction (SD) is frequently encountered in patients suffering from depression. There is a bidirectional relationship between various types of SD and depression, so the presence or treatment of one condition may exacerbate or improve the other condition. The most frequent sexual problem in untreated depressed patients is declining sexual desire, while in treated depressed patients it is difficulties with erection/ejaculation and with orgasm. Numerous classes of neuropsychiatric medications, commonly used in depressed patients—such as antidepressant, antipsychotic, alpha sympathetic, and opioid drugs—may cause SD. Photobiomodulation (PBM) therapy, also called low-level light/laser therapy, is a novel neuromodulation technique for neuropsychiatric conditions, such as depression. Transcranial PBM (tPBM) targets the cellular metabolism—through the mitochondrial respiratory enzyme, cytochrome c oxidase—and has numerous cellular and physiological beneficial effects on the central nervous system. This paper represents a comprehensive review of the application of tPBM to SD, coexisting with depression or induced by antidepressant medications.
7
Mattar, Citra Nurfarah, Yap Seng Chong, Lin Lin Su, Anupriya Aditya Agarwal, PC Wong und Mahesh Choolani. „Care of Women in Menopause: Sexual Function, Dysfunction and Therapeutic Modalities“. Annals of the Academy of Medicine, Singapore 37, Nr. 3 (15.03.2008): 215–23. http://dx.doi.org/10.47102/annals-acadmedsg.v37n3p215.
Der volle Inhalt der QuelleAnnotation:
Introduction: The physiological changes that occur in menopause alter sexual function and affect well-being. Hormonal changes contribute significantly to reduced sexual function in older women and sexual dysfunction may well be amenable to treatment with exogenous hormones or other agents. Materials and Methods: Relevant clinical studies were identified by a computerised literature search. The collated data were presented to fellow gynaecologists for review, analysis of results and discussion in a series of meetings dedicated to finding the best evidence in menopause management. The evidence was assessed and used to prepare guidelines around the management of women who are affected by sexual dysfunction in menopause. Results: Hormone therapy benefits many women who have dyspareunia related to vaginal atrophy, reduced libido and decreased satisfaction, particularly if these symptoms adversely affect their quality of life. Alternative agents such as tibolone and sildenafil citrate can be useful adjuncts. Conclusions: It is increasingly important to recognise postmenopausal sexual dysfunction. Treatment of this syndrome must be individualised to the specific complaints of each woman. Hormones and other agents are relevant treatment options for properly-selected women. Key words: Androgen, Dyspareunia, Oestrogen, Postmenopause, Sex disorders
8
Kim, Young-Joo, und Sung Dae Kim. „Approach to clinical diagnosis and treatment of erectile dysfunction of man“. Journal of Medicine and Life Science 7, Nr. 2 (01.12.2010): 1–6. http://dx.doi.org/10.22730/jmls.2010.7.2.1.
Der volle Inhalt der QuelleAnnotation:
The sexual dysfunction of man is mainly divided into four parts as erectile dysfunction, sexual desire disorder. premature ejaculation and orgasmic disorder. Above of all things, erectile dysfunction is the most important and common disease of these. The past, it is regard to ereclile dysfunction of man is natural event according to aging and little effort to improve or treat about it. But as the molecular biology and pharmacology become more and more advanced, it comes from biological factor and is possible to overcome. The preference of therapeutic option in patients of erectile dysfunction is various but becomes less invasive therapy. The phosphodiesterase type-5 inhibitors (PDE5-ls) sildenafil, vardenafil, tadalafil, urodenafil and mirodenafil are widely used as IirsHine therapy for erecli1e dysfunction (ED). Since the approval of sildenafil in 1998, more than 40 million men worldwide have been successfully treated with PDE5-ls. Pharmacologically, the proven safely and high tolerance of PDE5-ls is an attractive tool to investigate further physiological functions of PDE5, for example the modulation of intracellular cyclic GMP (cGMP) pools. The aim of review is to summarize clinical knowledge and practical approach about erectile dysfunction of man and to share with non-urologist in these information. Therefore, we recommend that even though non-urologist, it is worthy to know of this review.
9
Fedorchenko, Yuliya, und Burhan Fatih Kocyigit. „PERSPECTIVES ON MALE AGING AND THERAPEUTIC IMPLICATIONS“. Central Asian Journal of Medical Hypotheses and Ethics 4, Nr. 3 (29.12.2023): 146–54. http://dx.doi.org/10.47316/cajmhe.2023.4.3.01.
Der volle Inhalt der QuelleAnnotation:
This article provides an in-depth analysis of the molecular and cellular alterations linked to the aging process in males. It elucidates the physiological disruptions that give rise to different diseases and a decrease in functional ability. The inquiry explores the complex correlation between aging, sexual dysfunction, and infertility in males, with a focus on the physiological alterations in spermatogonial stem cells and the impact of oxidative stress on male reproductive capacity. The function of testosterone replacement therapy and its potential advantages in enhancing sexual activity, bone density, and overall health in older males are highlighted. Nevertheless, it is prudent to exercise caution as there is a correlation between testosterone replacement therapy and heightened cardiovascular risk. The article summarizes rehabilitation options for elderly men, specifically focusing on exercise regimens and cardiac rehabilitation, as means to tackle erectile dysfunction and mitigate mortality risks. The advantages of yoga in enhancing mental and physical well-being in males, particularly those grappling with prostate cancer or infertility are mentioned. The significance of adopting a comprehensive and interdisciplinary strategy towards men's health is emphasized, with particular attention given to the contributions of primary care physicians, urologists, and nurses. The significance of customized communication tactics for males and the necessity of periodic examinations for promoting healthier aging are emphasized.
10
Gamidov, S. I., O. Kh Tazhetdinov, A. A. Pavlovichev, A. Iu Popova und R. A. Tkhagapsoeva. „Peculiarities of pathogenesis, diagnostics and treatment of erectile dysfunction in patients presenting with hypogonadism“. Problems of Endocrinology 56, Nr. 5 (15.10.2010): 33–42. http://dx.doi.org/10.14341/probl201056533-42.
Der volle Inhalt der QuelleAnnotation:
Different authors estimate the prevalence of hypogonadism and erectile dysfunction at 1.7% to 35%. The contribution of androgens playing an important role in regulation of erection remains the subject of extensive investigations. To date, experimental and clinical studies have demonstrated that androgen deficiency leads to degeneration and apoptosis of smooth muscle cells followed by fibrosis of cavernous bodies, impaired expression of endothelial and neuronal NO synthase, decreased arterial inflow and increased venous drainage of the cavernous bodies, enhanced sensitivity to mediators of vasoconstriction, impaired NO-mediated relaxation of smooth muscles in response to sexual stimulation, reduced expression of type 5 phosphodiesterase (PDE-5). Moreover, hypogonadism and erectile dysfunction are frequently associated with cardiovascular disorders, diabetes mellitus, metabolic syndrome, dyslipidemia, hypercholesterolemia, hypertriglyceridemia, and obesity. The main purpose of hormonal substitution therapy is to maximally normalize the physiological concentration of plasma testosterone and to eliminate clinical manifestations of androgen deficiency. The treatment with testosterone-containing preparations is indicated only for patients with clinical symptoms and laboratory findings suggestive of hypogonadism. The testosterone-based preparations for intramuscular administration currently find wide application for this purpose. Testosterone substitution therapy enhances libido, increases the frequency of morning erection, and improves sexual quality of life at large. It is worthy of note that treatment with these preparations is well tolerated by the patients. Control over hormonal substitution therapy with testosterone preparations implies evaluation of the clinical response and achievement of the target testosterone level in blood plasma. Also. it is necessary to measure PSA, perform digital rectal examination, and determine the hematocrit level prior to the initiation of the treatment, 3 and 6 months after its termination, and every 6 months thereafter. To conclude, androgens are natural stimulators maintaining sexual function in men. Patients with hypogonadism and erectile dysfunction should be managed by combined therapy with androgens and PDE-5 inhibitors.
Dissertationen zum Thema "Sexual dysfunction, physiological – therapy"
1
Schvartzman, Renata. „Intervenção fisioterapêutica em mulheres climatéricas com dispareunia : ensaio clínico randomizado“. reponame:Biblioteca Digital de Teses e Dissertações da UFRGS, 2016. http://hdl.handle.net/10183/150667.
Der volle Inhalt der QuelleAnnotation:
Base Teórica: As alterações do assoalho pélvico nas mulheres climatéricas, decorrentes das variações hormonais, de modificações fisiológicas e do próprio envelhecimento dos tecidos, podem ser responsáveis por disfunções urinárias e sexuais. O papel da fisioterapia no tratamento da incontinência urinária tem sido documentado, porém há poucos estudos avaliando a disfunção sexual. Objetivo: Avaliar o efeito da intervenção fisioterapêutica sobre a dor, a função sexual, a qualidade de vida e a funcionalidade da musculatura do assoalho pélvico em mulheres climatéricas com dispareunia. Métodos:Trata-se de um ensaio clínico randomizado que avaliou a função sexual (Índice de Função Sexual Feminina), a qualidade de vida (Escala Cervantes), a dor (Escala Análoga Visual da dor - EVA) e a funcionalidadeda musculatura do assoalho pélvico(Eletromiografia e Palpação Vaginal através da Escala New Perfect) antes e após dois tratamentos.No grupo intervenção foi aplicada a termoterapiada musculatura do assoalho pélvico (MAP), liberaçãomanual dos ponto-gatilhos miofasciaisda MAP e treinamento dessa musculatura durante cinco sessões; no grupo controlefoi aplicada a termoterapia na região lombar e realizadaa liberação manual miofascial das musculaturas diafragma abdominal, piriforme, e iliopsoas, sem envolvimento da MAP.O desfecho principal foi o efeito da intervenção sobre o grau de dor (dispareunia) e os desfechos secundários foram o efeito da intervenção na função sexual, qualidade de vida e funcionalidade da MAP. Resultados: Foram incluídas no estudo 42 mulheres climatéricas com dispareunia (média de idade 51,3 ± 5,0),foram incluídas. Os escores de dor no grupo intervenção diminuiu de 7,77 ± 0,38 para 2,25 ± 0,30; e no grupo controle, de 7,62 ± 0,29 para 5,58 ± 0,49 (p <0,001). A intervenção realizada diretamente na MAP foi associada a uma redução estatisticamente significativa nos escores de dor,melhora nos escores da escala New Perfect, nos escores totais do IFSF e da escala de qualidade de vida (Cervantes) Conclusão: O protocolo de fisioterapia proposto foi eficaz para a melhora da dispareunia, da qualidade de vida, da função sexual e da funcionalidade da MAP em mulheres climatéricas com dispareunia.Background:Alterations in the pelvic floor during menopausal years, which are the result of hormonal and physical changes and of tissue aging itself, can lead to urinary and sexual dysfunction. The role of physical therapy in the treatment of urinary incontinence is well documented, but few studies have assessed its role in sexual dysfunction. Objective:To evaluate the effect of a physical therapy intervention on pain, sexual function, quality of life, and pelvic floor muscle function in climacteric women with dyspareunia. Methods:The present randomized controlled trial evaluated sexual function (Female Sexual Function Index), quality of life (Cervantes scale), pain (10-point visual analogue scale), and pelvic floor muscle function (electromyography and vaginal palpation/New PERFECT scale)before and after two treatments: the intervention group received pelvic floor thermal stimulation, myofascial release of pelvic floor muscle trigger points, and pelvic floor muscle training during five weekly sessions; in the control group, heat was applied to the lower back with myofascial release of abdominal diaphragm, piriformis, and iliopsoas muscles, with no involvement of pelvic floor muscles. The main outcome measure was the effect of the intervention on the degree of pain (dyspareunia). Secondary outcomes were post-treatment sexual function, quality of life, and pelvic floor muscle function. Results: Forty-two climacteric women with dyspareunia (mean age 51.3 ± 5.0 years) were studied. Pain scores in the intervention group decreased from 7.77±0.38 to 2.25±0.30; and in the control group, from 7.62±0.29 to 5.58±0.49, (statistically significant interaction effect (p<0.001). The intervention was associated with statistically significant improvement in pain scores, overall Female Sexual Function Index score, New PERFECT scores, and quality of life scores. Conclusion: The proposed physical therapy protocol was effective to improve pain, quality of life, sexual function, and pelvic floor muscle function in climacteric women with dyspareunia.
2
Lanza, Ana Helena Barbosa 1958. „Efeito de um programa de exercícios cinesioterapêuticos sobre a contratilidade do assoalho pélvico de mulheres com disfunção de orgasmo = avaliação eletromiográfica“. [s.n.], 2011. http://repositorio.unicamp.br/jspui/handle/REPOSIP/308663.
Der volle Inhalt der QuelleAnnotation:
Orientadores: Cássio Luis Zannettini Riccetto, Simone Botelho PereiraDissertação (mestrado) - Universidade Estadual de Campinas, Faculdade de Ciências Médicas
Made available in DSpace on 2018-08-20T03:58:07Z (GMT). No. of bitstreams: 1 Lanza_AnaHelenaBarbosa_M.pdf: 1640627 bytes, checksum: c135a5857fcde47208c0a3c7f837045b (MD5) Previous issue date: 2011
Resumo: Objetivo. Avaliar o efeito de um programa supervisionado de cinesioterapia sobre a contratilidade do assoalho pélvico, e sua eventual correlação com a função orgásmica feminina. Sujeito e Métodos. Para este estudo clínico, prospectivo, randomizado, controlado e cego, foram inclusas 20 mulheres, com média de idade de 26,6 ± 6,1 anos, com queixa de falta de orgasmo durante a atividade sexual, as quais foram divididas aleatoriamente em dois grupos. Grupo 1 (G1): 10 mulheres; avaliadas quanto à função orgásmica e quanto à contratilidade muscular do assoalho pélvico; realizaram um protocolo de exercícios cinesioterapêuticos (12 sessões individuais, com duração de 30 minutos, duas vezes por semana), focado no fortalecimento muscular pélvico; e reavaliada quanto à função orgásmica e quanto à contratilidade muscular; Grupo 2 (G2): 10 mulheres; avaliadas quanto à função orgásmica e quanto à contratilidade muscular do assoalho pélvico; não realizaram o protocolo de exercícios cinesioterapêuticos; foram reavaliadas quanto à função orgásmica e quanto à contratilidade muscular simultaneamente às mulheres do G1, sendo denominado G2-Controle. Após uma semana, esse grupo realizou o mesmo protocolo de exercícios cinesioterapêuticos, foi reavaliado quanto à função orgásmica e quanto à contratilidade muscular, sendo denominado G2-Tratado. A função orgásmica foi avaliada por meio do domínio orgasmo do questionário validado para língua portuguesa Female Sexual Function Index (FSFI), e por meio do cálculo do Coeficiente de Capacidade Orgásmica (CCO). As avaliações da contratilidade muscular do assoalho pélvico foram realizadas por segundo pesquisador, o qual não tinha conhecimento do programa de tratamento, através de palpação digital (PD) e de eletromiografia de superficie (EMGs - com sensor intravaginal), enquanto que, o programa de exercícios cinesioterapêuticos foi elaborado e supervisionado por pesquisador, o qual não participou das avaliações da contratilidade muscular do assoalho pélvico. O questionário International Consultation on Incontinence Questionnaire Short-Form, validado para a língua portuguesa, foi aplicado na avaliação inicial, no intuito de verificar a coexistência da incontinência urinária. Para análise estatística foram utilizados o Teste t de Student, o Teste de Correlação de Pearson, e o Teste Regressão Linear Simples, com nível de significância de 5%. Resultados. Em contraste com o grupo controle (G2-Controle), os grupos que realizaram o programa de exercícios cinesioterapêuticos proposto (G1 e G2-Tratado) apresentaram aumento significativo na contratilidade do assoalho pélvico, tanto a avaliada pela PD (p<0,001), quanto a mensurada pela EMGs (p<0,001), e este aumento de contratilidade se correlacionou de forma significativa com a melhora no escore do domínio orgasmo do FSFI (p<0,001), e no escore do Coeficiente de Capacidade Orgásmica (p=0,001). Conclusão. O programa de exercícios cinesioterapêuticos proposto promoveu aumento na contratilidade do assoalho pélvico, com concomitante melhora da função orgásmica, indicando que essa abordagem terapêutica possa ser adjuvante no tratamento da disfunção orgásmica feminina
Abstract: Objective. Evaluate the effect of a protocol supervised of the kinesiotherapy on the contractility of the pelvic floor, and its possible correlation with female orgasmic function. Subjects and methods. For this clinical, prospective, randomized, controlled, blind study, were included 20 women, mean age 26.6 ± 6.1 years, complaining of lack of orgasm during sexual activity, which were randomly divided into two groups. Group 1 (G1): 10 women, evaluated for orgasmic function and on the contractility of the pelvic floor, made a kinesiotherapy protocol (12 sessions, lasting 30 minutes, twice a week), focused on muscle strengthening, and reassessed as the orgasmic function and the contractility of the pelvic floor; Group 2 (G2): 10 women, evaluated for orgasmic function and on the contractility of the pelvic floor, did not realize the kinesiotherapy protocol, were reassessed on the orgasmic function and on the contractility of the pelvic floor while the women in the G1, and called G2- Control. After one week, this group received the same kinesiotherapy protocol, was reassessed as the orgasmic function and on the contractility of the pelvic floor, and called G2- Treaty. Orgasmic function was assessed using the orgasm domain of the validated questionnaire to portuguese Female Sexual Function Index (FSFI), and by calculating the Coefficient of Orgasmic Capacity (COC). The assessments of the pelvic floor muscle contractility were performed by the second researcher, which was not aware of the treatment program, by digital palpation (DP) and surface electromyography (sEMG - with intravaginal sensor), while kinesiotherapy program was drafted and supervised by a researcher no involved in the assessments of contractility of the pelvic floor. The International Consultation on Incontinence Questionnaire, validated for the portuguese language was used in the initial assessment, in order to verify the coexistence of urinary incontinence. Statistical analysis was performed using the Student t Test, the Pearson Correlation Test, and the Simple Linear Regression Test, with a significance level of 5%. Results. In contrast to the control group xvi (G2-control), groups that performed kinesiotherapy (G1 and G2-Treaty) showed a significant increase in contractility of the pelvic floor, assessed by PD (p <0,001), and measured by EMG (p <0.001), and this increase in contractility was positively correlated with the improvement in the orgasm domain score of the FSFI (p <0,001), and the score of the Coefficient Orgasmic Capacity (p = 0,001). Conclusion. The kinesiotherapy exercises program promoted increase in contractility of the pelvic floor, with concomitant improvement in orgasmic function, indicating that this therapeutic approach could be an adjunct in the treatment of female orgasmic dysfunction
Mestrado
Fisiopatologia Cirúrgica
Mestre em Ciências da Cirurgia
3
Nunes, Luciana Vargas Alves [UNIFESP]. „A acurácia da Escala de Experiência Sexual do Arizona (ASEX) para identificar disfunção sexual em pacientes do espectro da esquizofrenia“. Universidade Federal de São Paulo (UNIFESP), 2009. http://repositorio.unifesp.br/handle/11600/8805.
Der volle Inhalt der QuelleAnnotation:
Made available in DSpace on 2015-07-22T20:49:11Z (GMT). No. of bitstreams: 0
Previous issue date: 2009-02-27. Added 1 bitstream(s) on 2015-08-11T03:25:33Z : No. of bitstreams: 1
Publico-008.pdf: 1147299 bytes, checksum: c53fe718c40d4278be6155456942dfbe (MD5)Contexto: a disfunção sexual é frequente entre pacientes com esquizofrenia, sendo relatada como um dos mais incômodos efeitos adversos dos antipsicóticos e esta diretamente relacionada com adesão ao tratamento. Objetivo: a) avaliar a frequência da disfunção sexual em uma amostra de pacientes do espectro da esquizofrenia em tratamento com antipsicóticos; b) investigar 0 efeito dos diferentes antipsicóticos na função sexual; e c) avaliar a acurácia da Escala de Experiência Sexual do Arizona (AS EX) para identificar disfunção sexual. Método: pacientes ambulatoriais com esquizofrenia ou transtorno esquizoafetivo foram entrevistados através de questionários: ASEX e Escala Dickson-Glazer (DGSFi) para avaliação do funcionamento sexual, em uma única entrevista. Resultados: 137 pacientes foram entrevistados. A sensibilidade e especificidade da ASEX em relação a DGSFi foram: 80.8% ( 95% IC= 70.0%-88.5%) e 88.1 % (95% IC=76.5%-94.7%), e a taxa de classificação incorreta foi 9.5%. A curva ROC comparando a pontuação da ASEX e DGSFi revelou valor de 0.93 (IC=0.879¬0.970) com 0 ponto de corte da ASEX encontrando sendo 14/15. A disfunção sexual foi mais alta entre as mulheres (79.2%) do que nos homens (33.3%) (X2=27.41, gl=1, p<0.001). Conclusão: pacientes em tratamento com antipsicóticos mostraram alta frequência de queixas sexuais e ASEX provou ser um instrumento eficaz para identificar disfunção sexual em amostra de pacientes ambulatoriais do espectro da esquizofrenia. Mulheres mostraram frequência mais alta de disfunção, e desejo sexual e habilidade para alcançar orgasmo foram áreas mais afetadas. 0 uso de antipsicóticos, principal mente 0 uso de combinações, foi associado com piora do funcionamento sexual..
Background: sexual dysfunction is frequent in patients with schizophrenia, it is reported as one of the most distressing antipsychotic’s adverse effects and it is directly related to treatment compliance. Objective: a) to assess the frequency of sexual dysfunction in a sample of outpatients with schizophrenia and schizoaffective disorder under antipsychotic therapy; b) to investigate the effect of different antipsychotics on sexual function; and c) to evaluate the accuracy of the Arizona Sexual Experience Scale (ASEX) to identify sexual dysfunction. Method: Outpatients with schizophrenia or schizoaffective disorder were asked to fulfill both the ASEX and the Dickson Glazer Scale for the Assessment of Sexual Functioning Inventory (DGSFi) at a single interview. Results: 137 patients were interwied. The sensitivity and specificity of the ASEX in relation to DGSFi were: 80.8%, (95% CI= 70.0%-88.5%) and 88.1% (95% CI= 76.5%-94.7%), and the misclassification rate was 9.5%. The ROC curve comparing the ASEX and the DGSFi scores revealed a value of 0.93 (CI= 0.879-0.970), with the optimum cut-off point of ASEX being 14/15. Sexual dysfunction measured was higher in females (79.2%) than in males (33.3%) (2 = 27.41, d.f.=1, p<0.001). Discussion: Patients under antipsychotic treatment showed a high level of sexual complaints, and the ASEX proved to be an accurate instrument to identify sexual dysfunction in an outpatient sample of patients with schizophrenia spectrum. Females showed a higher frequency of sexual dysfunctions and sexual drive and ability to reach orgasm were the most affected areas. The use of antipsychotics, especially the combinations, was more likely to impair sexual functioning.
TEDE
BV UNIFESP: Teses e dissertações
4
Fawcett, David. „The Influence of Profession and Therapy Type for the Cost Effective Treatment of Sexual Dysfunction“. BYU ScholarsArchive, 2011. https://scholarsarchive.byu.edu/etd/3017.
Der volle Inhalt der QuelleAnnotation:
Sexual dysfunctions are serious mental health issues that impact an estimated one in three Americans. Due to the complex, relational nature of most sexual dysfunctions, mental health professionals trained to work with couples and their relationship interactions are likely to have better outcomes when treating clients with sexual dysfunction. Data from CIGNA Health Solutions was analyzed to explore differences in therapy outcome for various types of mental health professions when treating clients with sexual dysfunctions. The current research is a retrospective analysis of administrative data that explores whether or not type of profession (i.e. psychologists, Masters of social work, marriage and family therapist, or professional counselor) influences the outcome of mental health treatment. This study also explores whether therapy modality (i.e. individual, conjoint, or mixed mode, a combination of individual and conjoint therapy) influences therapy outcome. Treatment outcome was measured by recidivism rates, client drop out from therapy, the total number of sessions, and cost of treatment. Participants included 230 males and 189 females ages 18 to 101 (M =38.9, SD = 11.4) who received treatment for sexual disorders from 2001 to 2006. Participants were from all regions of the United States. Results indicate that overall, psychotherapeutic treatment for sexual dysfunctions is relatively brief, averaging about seven sessions across all professions. Results suggest that marriage and family therapists treat sexual dysfunctions using a conjoint and mixed mode approach more frequently than therapists with other licenses. Results also suggest that mixed mode therapy has drastically lower dropout rates and longer retention than individual or conjoint therapy. These results suggest that utilizing a combination of relational and individual sessions is beneficial to the treatment of sexual dysfunctions.
5
Regadas, Rommel Prata. „Efeito do creme de jambu (acmella oleracea) sobre a funÃÃo sexual masculina e feminina“. Universidade Federal do CearÃ, 2008. http://www.teses.ufc.br/tde_busca/arquivo.php?codArquivo=2582.
Der volle Inhalt der QuelleAnnotation:
CoordenaÃÃo de AperfeiÃoamento de NÃvel SuperiorO Jambu (Spilanthes oleracea ou Spilanthes acmella var oleracea ou Acnella oleracea) à uma planta tÃpica da regiÃo norte do Brasil, mais precisamente do ParÃ. à utilizado na culinÃria paraense, fazendo parte do prato de peixes como o TacacÃ, o Pato no Tucupi. AlÃm da utilizaÃÃo na culinÃria, tem tido outras aplicaÃÃes, principalmente como analgÃsica, anti-inflamatÃria e antifÃngica. Recentemente, tem sido utilizado como estimulante sexual em mulheres. Segundo a cultura popular, o aumento da excitaÃÃo feminina decorreria de uma atividade contrÃtil (aumento do peristaltismo) na vulva. Entretanto, nenhum estudo bem conduzido foi publicado na literatura mÃdica para confirmar se isso à realmente verdade. O presente estudo teve como objetivo avaliar se a pomada de Jambu realmente aumenta a excitaÃÃo e o desejo sexual feminino; se ocasiona algum impacto sobre o desejo e a satisfaÃÃo sexual masculina e, por fim, observar a sua seguranÃa e tolerabilidade. Dois ensaios clÃnicos randomizados, cruzados e placebo-controlados, foram realizados ao mesmo tempo: um para avaliar os homens que utilizaram o creme e o placebo e outro para avaliar as mulheres. Vinte e dois casais participaram do estudo. Utilizaram, durante as relaÃÃes sexuais, o creme de JAMBU e o placebo. Foram avaliados separadamente, por questionÃrios auto-aplicÃveis, antes e apÃs a utilizaÃÃo de cada pomada. Os questionÃrios utilizados foram o Ãndice Internacional de FunÃÃo ErÃtil (IIEF) e o Ãndice de Funcionamento Sexual Feminino (FSFI). A mÃdia de idade foi de 43,3 anos para os homens e de 40,5 anos para as mulheres. Verificou-se que, apÃs o tratamento, o desejo e a satisfaÃÃo sexual mensurados no grupo Jambu foram significantemente maiores que o observado no grupo Placebo, nos homens (P = 0,0008 e P = 0,0006, respectivamente). O desejo e a excitaÃÃo sexual na mulher mensurados no grupo Jambu tambÃm foram significantemente maiores que o observado no grupo Placebo (P = 0,0006 e P = 0,0005, respectivamente). Igualmente, apenas no grupo Jambu, houve um aumento significante sobre o desejo e a satisfaÃÃo sexual nos homens e sobre o desejo e a excitaÃÃo nas mulheres, apÃs o tratamento quando comparado aos valores basais (P = 0,0002 e P = 0,0003) e (P = 0,0001 e P = 0,0008, respectivamente). O mesmo nÃo ocorreu com o placebo. NÃo foi constatada diferenÃa estatisticamente significante em relaÃÃo à alteraÃÃo no tempo ejaculatÃrio (P = 0,7768) entre os grupos placebo e Jambu. TambÃm nÃo foi constatada diferenÃa estatisticamente significante em relaÃÃo à dor ou desconforto apÃs a utilizaÃÃo das pomadas, tanto no grupo masculino quanto no grupo feminino, (P = 0,7728 e P = 1,0000) entre os dois grupos. Conclui-se que o creme de Jambu (Acmella oleracea) aumentou a excitaÃÃo e o desejo sexual feminino e o desejo e a satisfaÃÃo sexual masculina durante atividade sexual, quando comparada ao placebo. NÃo houve alteraÃÃo no tempo ejaculatÃrio dos pacientes que utilizaram o creme. Os efeitos colaterais foram discretos e cessaram apÃs a sua remoÃÃo.
The toothache plant (Spilanthes oleracea or Spilanthes acmella oleracea or simply Acmella oleracea) is a well-known herb in Northern Brazil, especially in ParÃ, where it is referred to as jambu. Though commonly used in the local cuisine in dishes such as tacacà and pato-no-tucupi, it is also widely used to prepare analgesic, antiinflammatory and antifungal medications. Extracts of this plant have recently become popular as a topical sexual stimulant for women. The active substance in the herb, spilanthol, is believed to contract the vulva, but so far no medical study has been published confirming this. In the present randomized, double-blind, placebo-controlled crossover clinical study a cream was prepared from extracts of the toothache plant and tested with regard to its effect on female sexual desire and excitation and male sexual desire and satisfaction and ejaculation time, along with safety and tolerability. Twenty-two blinded couples used cream with and without extract of A. oleracea during two periods of 4 weeks. The participants were aged 43.3 years (men) and 40.5 years (women) on the average and were evaluated individually using self-reported questionnaires (the International Index of Erectile Function and The Female Sexual Function Index) before and after the use of each cream. Compared to placebo, male sexual desire and satisfaction (p=0.0008 and p=0.0006, respectively) and female sexual desire and excitation (p=0.0006 and p=0.0005, respectively) were significantly greater when couples were using the extract. Likewise, male sexual desire and satisfaction (p=0.0002 and p=0.0003, respectively) and female sexual desire and excitation (p=0.0001 and p=0.0008, respectively) only increased in relation to baseline values when couples were using extract. No significant differences were observed between extract and placebo with regard to ejaculation time (p=0.7768), nor with regard to pain and discomfort after intercourse, as reported by both genders (p=0.7728 and p=1.0000, respectively). It may be concluded that cream prepared from extracts of the toothache plant increased female sexual desire and excitation and male sexual desire and satisfaction during intercourse compared to placebo and baseline, without affecting ejaculation time. Side effects were negligible and subsided after completion of treatment.
6
Hagey, Derek Willis. „Collaborative treatment of erectile dysfunction: thoughts from the membership of the Sexual Medicine Society of North America“. Diss., Kansas State University, 2012. http://hdl.handle.net/2097/13791.
Der volle Inhalt der QuelleAnnotation:
Doctor of PhilosophyDepartment of Family Studies and Human Services
Sandra Stith
Recent years have seen a rise in the medicalization of treatments for erectile dysfunction (ED). While there has been a divide between the medical and psychological communities, some have called for a more collaborative relationship. Little research has been done on the collaboration between medical professionals and psychotherapists in treating ED. This study seeks to increase current knowledge about medical professionals’ referral practices and communication post-referral. An online survey was developed and distributed to the members of the Sexual Medicine Society of North America (SMSNA) (N = 541). Survey questions inquired as to the factors that increased participants’ willingness to refer ED patients, the form of communication participants currently desire to have with psychotherapists and the participants’ desired level of communication with psychotherapists to whom they might refer. Less than ten percent of the medical professionals invited to participate in the study completed the survey (n=50). Those who did complete the survey were primarily male, specialized in urology and practiced in the U.S. Almost half the respondents were employed in an academic setting while just over half of respondents worked in hospital-based, group, or solo practices. Just over half of the survey participants practiced in urban areas. Although the number of medical professionals who completed the survey was small, findings indicated that those who completed a sexual medicine fellowship and who had a larger percentage of their patient population being seen for ED were more likely to refer patients to psychotherapists. Participants who have referred ED patients to psychotherapists reported little-to-no communication between them and the psychotherapists to whom they refer. The study participants expressed a desire to refer patients to psychotherapists who are experienced in working with both sexual and couples issues. Questions about the desires and experiences of medical professionals who have not referred to psychotherapists were not able to be answered because of the limited number of these individuals in the data set. Although the number of participants who completed the survey limits the generalizability of the data, this study demonstrates that most medical professionals who responded to the survey are willing to refer ED patients to psychotherapists.
7
Wilson, Jerika. „Who’s Coming to Sex Therapy? Exploring Black Women’s Willingness to Seek Treatment for Sexual Problems/Dysfunctions“. University of Cincinnati / OhioLINK, 2016. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1479816476417109.
Der volle Inhalt der Quelle
8
Souto, Sophia Consuelo 1983. „Impacto da aplicação topica do gel doador de oxido nitrico no fluxo sanguineo clitoridiano, avaliado pelo ultra-som Doppler“. [s.n.], 2008. http://repositorio.unicamp.br/jspui/handle/REPOSIP/311594.
Der volle Inhalt der QuelleAnnotation:
Orientadores: Paulo Cesar Rodrigues Palma, Cassio Luis Zanettini RiccettoDissertação (mestrado) - Universidade Estadual de Campinas, Faculdade de Ciencias Medicas
Made available in DSpace on 2018-08-11T15:13:42Z (GMT). No. of bitstreams: 1 Souto_SophiaConsuelo_M.pdf: 4211847 bytes, checksum: 42d0aabe09e9a27f66e06e5f8b6d381f (MD5) Previous issue date: 2008
Resumo: Introdução: O sexo é parte do cotidiano das pessoas não estando limitado à concepção. Diversos fatores podem inibir a resposta sexual da mulher, tanto de forma transitória como prolongada. A resposta sexual sofre efeitos da: idade, tabaco, colesterol, hipertensão e diabetes. É uma condição multifatorial, com componentes anatômicos, fisiológicos, médicos, psicológicos e sociais. (Wyman JF; et al, 1987) O aumento do fluxo sanguíneo clitoridiano ocorre em decorrência do estímulo sexual, sendo parte da resposta sexual feminina. (Levin RJ, 1980) Sendo, portanto, uma boa forma de avaliar um método de tratamento para disfunção sexual feminina. O óxido nítrico (NO) e peptídeos vasoativos intestinais estão implicados no ingurgitamento de tecido clitoridiano após estimulação sexual. O NO constitui uma das menores e mais simples moléculas biossintetizadas, é um radical livre, gasoso, inorgânico, incolor, que possui sete elétrons do nitrogênio e oito do oxigênio, tendo um elétron de oxigênio desemparelhado. (Beckman JS & Koppenol WH, 1996) Objetivo Avaliar através do exame de ultra-sonografia Doppler se a aplicação tópica de um gel doador de óxido nítrico aumentaria o fluxo sanguíneo clitoridiano de mulheres normais. Materiais e Métodos No presente estudo, foram avaliadas vinte mulheres normais das quais passaram por exame de ultra-sonografia Doppler na artéria clitoridiana, comparando o fluxo sanguíneo normal e o fluxo sanguíneo com a utilização do gel doador de óxido nítrico. A analise hemodinâmíca constou de: velocidade sistólica de pico, velocidade diastólica e índice de resistência do vaso. Resultados: Na análise estatística verificou-se diferença significância para todos os parâmetros estudados (p < 0,05). A velocidade sistólíca mediana inicial foi de 104 e após aplicação do gel doador de óxido nítrico foi de 109 (p=0,002). A velocidade diastólica mediana inicial foi de 107 e após aplicação do gel passou a 106 (p=0,043) e a resistência mediana inicial foi de 105 e após aplicação do gel tornou-se 107 (p=0,005). Conclusão: Concluímos que a utilização tópica deste gel doador de óxido nítrico foi eficaz para aumentar o fluxo sanguíneo na região clitoridiana
Abstract: Introduction Sex is a part of the daily life of people and it is not just limited to conception. Different factors may inhibit female's sexual response, in a transitory or prolonged way. The sexual response is affected by age, tobacco, cholesterol, hypertension and diabetes. It is a multifactor condition, with anatomical, physiological, medical, psychological and social factors. (Wyman JF; et al, 1987) The increase of blood flow in the clitoris is due to sexual stimulation, being a part of the female's sexual response. (Levin RJ, 1980) That makes it a good way to asses a treatment for female sexual dysfunction. The nitric oxide (NO) and intestinal vase active peptides are involved in the ingurgitation of clitoridean tissue after sexual stimulation. The nitric oxide is one of the smallest and most simple biosynthesized molecules, and it is a gaseous, inorganic, colorless free radical, with seven electrons from nitrogen and eight from oxygen, and one oxygen electron is uneven. (Beckman JS & Koppenol WH, 1996) Objective Evaluate through the Doppler ultra-sound if the topic use of a nitric oxide donor gel would increase the blood flow in the clitoris of healthy women. Materials and method In this study we evaluated twenty healthy women who underwent ultrasound of the clitoris artery, comparing the normal blood flow and the flow with the use of the gel. The hemodynamic analysis considered: systolic peak speed, diastolic speed and vase resistance index. Results In the statistical analysis we found significant statistical differences in all the parameters measured (p < 0,05). The mean initial systolic speed was 104 and after the gel use it was 109 (p=0,002). The mean initial diastolic speed was 107 and with Abstract the gel it was 106 (p=0,043) and the mean initial resistance was 105 and after the use of the gel it was 107 (p=0,005). Conclusion The use of the topic gel proved to be effective to increase the blood flow in the area of the clitoris
Mestrado
Pesquisa Experimental
Mestre em Cirurgia
9
Castelo, Ana Rita Pimentel. „Application of Female Sexual Function Index in mastectomized and non-mastectomized women: a comparative study“. Universidade Federal do CearÃ, 2014. http://www.teses.ufc.br/tde_busca/arquivo.php?codArquivo=18456.
Der volle Inhalt der QuelleAnnotation:
Breast cancer is a public health problem in the world, it is estimated that more than 1 million women are diagnosed with the disease each year. It is most frequent in all regions of the country except in the north. With this, the mastectomy woman experiences a moment of emotional and sexual weakness, as the breast, symbol of femininity, plays an important role in the exercise of sexuality. The objectives of this study were to assess female sexual dysfunction in a group of women who underwent mastectomy and not mastectomy from the application of the Female Sexual Function Index; determine the incidence of female sexual dysfunction among women with mastectomies mastectomy and not women; and the correlation between the scores of the FSFI and personal history, clinical signs, symptoms and complaints related to sexuality in both groups. Developed a cross-sectional comparative study conducted in the Integrated Regional Oncology Center (CRYO), Association of Women in Cearà Mastectomized - Touch of Life and the Center for Family Development (CEDEFAM). . Data collection occurred in the period January-February 2014 As the sample consisted of two groups: 73 women who underwent mastectomy and 62 women without a diagnosis of breast cancer. The Female Sexual Function Index (FSFI), and a socioeconomic questionnaire and gynecological obstetric was applied. Descriptive statistics (absolute and relative frequencies, mean and standard deviation) was performed and the means to test the F Snedecor test (ANOVA) was applied. Most women with mastectomies investigated concentrated in the age group above 42 years (75.3%), while non-mastectomy women concentrated in the age group 18-36 years (66.1%). When analyzing the prevalence of sexual dysfunction in this study it was observed that was 55.6%. It was observed that the group of women with breast CA only field lubrication statistically significant when compared with age. Regarding monthly sex in the group of women who underwent mastectomy, it can be noticed that there was a statistically significant correlation in all domains of FSFI scale, except the pain domain (p> 0.05). Introducing the positive test r, this shows that the more sex these women have greater desire, arousal, lubrication, orgasm and satisfaction. The Cronbach alpha of the FSFI was 0.95 indicating high internal consistency and construct validity was assessed by the coefficient of linear correlation (p = 0.0001), demonstrating correlation between domains of scale. Therefore, we conclude that the nurse who assists women in general should provide quality care for all the obstacles are minimized to promote quality of life and sexual.O cÃncer de mama à um problema de saÃde pÃblica no mundo, pois se estima que mais de 1 milhÃo de mulheres sejam diagnosticadas com a doenÃa a cada ano. à o mais frequente em todas as regiÃes do paÃs, exceto na RegiÃo Norte. Com isso, a mulher mastectomizada vivencia um momento de fragilidade emocional e sexual, jà que a mama, sÃmbolo de feminilidade, exerce importante papel no exercÃcio da sexualidade. Os objetivos deste estudo foram avaliar a disfunÃÃo sexual feminina em um grupo de mulheres mastectomizadas e nÃo mastectomizadas a partir da aplicaÃÃo do Female Sexual Function Index; verificar a incidÃncia da disfunÃÃo sexual feminina entre as mulheres mastectomizadas e das mulheres nÃo mastectomizadas; e verificar a correlaÃÃo entre os escores da FSFI e os antecedentes pessoais, clÃnicos, queixas e sintomas relacionados à sexualidade nos dois grupos avaliados. Desenvolveu-se um estudo transversal, comparativo realizado no Centro Regional Integrado de Oncologia (CRIO), na AssociaÃÃo Cearense das Mulheres Mastectomizadas - Toque de Vida e no Centro de Desenvolvimento Familiar (CEDEFAM). A coleta de dados ocorreu no perÃodo de janeiro a fevereiro de 2014. Sendo a amostra composta por dois grupos: 73 mulheres mastectomizadas e 62 mulheres sem diagnÃstico de cÃncer de mama. Foi aplicado a Female Sexual Function Index (FSFI), e um questionÃrio socioeconÃmico e gineco-obstÃtrico. Foi realizada anÃlise estatÃstica descritiva (frequÃncias absoluta e relativa, mÃdia e desvio padrÃo) e para se testar as mÃdias foi aplicado o teste F de Snedecor (ANOVA). A maioria das mulheres mastectomizadas investigadas concentrou-se na faixa etÃria acima de 42 anos (75,3%), enquanto as mulheres nÃo mastectomizadas concentrou-se na faixa etÃria de 18 a 36 anos (66,1%). Ao analisarmos a prevalÃncia de disfunÃÃo sexual neste estudo observa-se que foi de 55,6%. Foi possÃvel observar que no grupo de mulheres com CA de mama somente o domÃnio lubrificaÃÃo apresentou significÃncia estatÃstica quando comparado com a idade. Quanto Ãs relaÃÃes sexuais mensais no grupo das mulheres mastectomizadas, percebe-se que houve correlaÃÃo estatisticamente significante em todos os domÃnios da escala FSFI, exceto no domÃnio dor (p>0,05). Apresentando o teste r positivo, isso demonstra que quanto mais relaÃÃes sexuais essas mulheres tiverem maior serà o desejo, a excitaÃÃo, a lubrificaÃÃo, o orgasmo e a satisfaÃÃo. O alfa de Cronbach da FSFI foi de 0,95 indicando alta consistÃncia interna e a validade de construto foi analisada por meio do coeficiente de correlaÃÃo linear de Pearson (p=0,0001), demonstrando correlaÃÃo entre os domÃnios da escala. Logo, podemos concluir que o enfermeiro que assiste a mulher de um modo geral deve prestar assistÃncia qualificada para que todos os obstÃculos sejam minimizados para favorecer a qualidade de vida e sexual.
10
Marino, Flávia Fairbanks Lima de Oliveira. „Aspectos da sexualidade em mulheres com endometriose“. Universidade de São Paulo, 2016. http://www.teses.usp.br/teses/disponiveis/5/5139/tde-06122016-155542/.
Der volle Inhalt der QuelleAnnotation:
INTRODUÇÃO: A endometriose é uma doença com impacto negativo em diversos aspectos da vida da mulher, inclusive na função sexual. Seus principais sintomas, representados por dor e infertilidade, relacionam-se diretamente com prejuízos na atividade sexual, mas aspectos específicos da função sexual dessas mulheres permanecem obscuros, o que motivou a realização deste estudo. DESENHO DO ESTUDO: coorte transversal. LOCAL: Ambulatório de Endometriose e Ginecologia Geral do Hospital das Clínicas da FMUSP e Ambulatório da Unidade Básica de Saúde da Prefeitura do Município de São Paulo. PACIENTES: 1001 mulheres divididas em 2 grupos, de acordo com a presença ou ausência de endometriose. INTERVENÇÕES: avaliação da função sexual, ansiedade e depressão das pacientes, correlacionando os resultados com sintomas, locais e tipos de endometriose e domínios da função sexual comprometidos. Avaliamos 1001 mulheres, consecutivamente, entre abril de 2013 e abril de 2015, sendo que 18 preencheram os formulários incorretamente. 294 mulheres (29,9%) foram excluídas por apresentarem ansiedade e depressão severas e 106 pacientes do grupo controle apresentavam sintomas que poderiam sugerir endometriose, logo também foram excluídas. O grupo final foi composto de 254 pacientes com endometriose e 329 pacientes sem a doença. Aplicamos os questionários para avaliação do escore da função sexual (Quociente Sexual Feminino - QSF), além dos inventários de Beck para ansiedade e depressão. Os dados foram tabulados e analisados através da aplicação dos testes estatísticos apropriados (Qui-quadrado, T de Student e Mann-Whitney). RESULTADOS: Nossos resultados mostraram que as pacientes com endometriose tiveram acometimento em todas as fases da resposta sexual, com significância estatística: desejo sexual, excitação sexual, dor na relação sexual e orgasmo/satisfação sexual. Na avaliação geral, 43,3% das pacientes com endometriose apresentaram disfunções sexuais, enquanto na população sem a doença as disfunções sexuais ocorreram em 17,6% das mulheres. Os fatores isolados que se correlacionaram à ocorrência de disfunções sexuais em geral foram a idade superior a 35 anos (OR = 1,97), dismenorreia (OR = 1,91), dispareunia (OR= 2,48) e algia pélvica crônica (OR = 1,88), refletindo a importância da sintomatologia da endometriose como desencadeante de disfunções sexuais. CONCLUSÃO: Pacientes com endometriose têm mais que o dobro de disfunções sexuais em relação à população sem a doençaINTRODUCTION: Endometriosis is a disease that negatively affects several aspects of a woman\'s life, including sexual function. The main symptoms of endometriosis - pain and infertility - are directly related to losses of sexual function, but which specific aspects of sexual function remains unclear. STUDY DESIGN: cross-sectional. SETTING: The outpatient clinics of the Endometriosis and General Gynecology Services of the Hospital das Clínicas of the USP School of Medicine and the Vila Regina (São Paulo) Municipal Primary Care Clinic. PATIENTS: 1001 women divided into two groups, according to the presence or absence of endometriosis. INTERVENTIONS: We assessed sexual function, anxiety and depression of patients and correlated these findings with symptoms, locations and types of endometriosis and the affected domains of sexual function. We recruited 1001 women seen consecutively between April 2013 and April 2015; 18 completed the forms incorrectly. 294 women (29.9%) were excluded due to severe anxiety and depression. 106 patients had symptoms that could have any relation to endometriosis, so they were also excluded. The final cohort was composed of 254 patients with endometriosis and 329 patients without the disease. Sexual function score was assessed using the Female Sexual Quotient (QSF); Beck inventories were used to assess anxiety and depression. The data were tabulated and analyzed by applying the appropriate statistical tests (Chi-square, Student\'s t and Mann-Whitney). RESULTS: Our results showed that patients with endometriosis were affected in all phases of sexual response, with statistical significance in three of them: sexual arousal, genital-pelvic pain/ penetration and orgasm/ sexual satisfaction. In the overall assessment, 43.3% of patients with endometriosis had sexual dysfunction, while the population without endometriosis sexual dysfunction occurred in 17.6% of women. Endometriosis conferred a relative risk of 52% (OR = 1.52) for the occurrence of sexual dysfunctions. CONCLUSION: Patients with endometriosis have double the sexual dysfunction as compared to women without the disease
Bücher zum Thema "Sexual dysfunction, physiological – therapy"
1
Richard, Balon, Hrsg. Sexual dysfunction. Basel: Karger, 2008.
Den vollen Inhalt der Quelle finden
2
Maggi, M. Hormonal therapy for male sexual dysfunction. Chichester, West Sussex, UK: Wiley-Blackwell, 2012.
Den vollen Inhalt der Quelle finden
3
Zaslau, Stanley. Dx/Rx: Sexual dysfunction. Sudbury, Mass: Jones & Bartlett Learning, 2012.
Den vollen Inhalt der Quelle finden
4
1944-, Charlton Randolph S., und Yalom Irvin D. 1931-, Hrsg. Treating sexual disorders. San Francisco, Calif: Jossy-Bass Publishers, 1997.
Den vollen Inhalt der Quelle finden
5
1944-, Charlton Randolph S., und Yalom Irvin D. 1931-, Hrsg. Treating sexual disorders. San Francisco: Jossy-Bass Publishers, 1997.
Den vollen Inhalt der Quelle finden
6
Hartman, William E. Treatment of sexual dysfunction: A basic approach. Northvale, N.J: Jason Aronson, 1994.
Den vollen Inhalt der Quelle finden
7
Wincze, John P. Enhancing sexuality: A problem-solving approach to treating dysfunction : workbook. 2. Aufl. Oxford: Oxford University Press, 2009.
Den vollen Inhalt der Quelle finden
8
Wincze, John P. Enhancing sexuality: A problem-solving approach to treating dysfunction : therapist guide. 2. Aufl. Oxford: Oxford University Press, 2009.
Den vollen Inhalt der Quelle finden
9
1948-, Weeks Gerald R., und Sendak Shelley K, Hrsg. A clinician's guide to systemic sex therapy. New York, NY: Brunner-Routledge, 2009.
Den vollen Inhalt der Quelle finden
10
Zaslau, Stanley. Dx/Rx: Sexual dysfunction in men and women. Sudbury, Mass: Jones & Bartlett Learning, 2012.
Den vollen Inhalt der Quelle findenBuchteile zum Thema "Sexual dysfunction, physiological – therapy"
1
LoPiccolo, Joseph. „Sexual Dysfunction“. In International Handbook of Behavior Modification and Therapy, 547–64. Boston, MA: Springer US, 1990. http://dx.doi.org/10.1007/978-1-4613-0523-1_26.
Der volle Inhalt der Quelle
2
Garcia, Francisco J., Eric Chung und Gerald Brock. „Drug therapy for erectile dysfunction“. In Male Sexual Dysfunction, 172–93. Chichester, UK: John Wiley & Sons, Ltd, 2016. http://dx.doi.org/10.1002/9781118746509.ch19.
Der volle Inhalt der Quelle
3
Gregory, Angela. „Psychosexual therapy for male sexual dysfunction“. In Male Sexual Dysfunction, 133–42. Chichester, UK: John Wiley & Sons, Ltd, 2016. http://dx.doi.org/10.1002/9781118746509.ch16.
Der volle Inhalt der Quelle
4
Rees, Rowland, und Victoria Dawson. „Non-surgical therapy for Peyronie's disease“. In Male Sexual Dysfunction, 229–35. Chichester, UK: John Wiley & Sons, Ltd, 2016. http://dx.doi.org/10.1002/9781118746509.ch24.
Der volle Inhalt der Quelle
5
Ridout, Ashley, Mark Emberton und Caroline Moore. „Sexual dysfunction and prostate cancer therapy“. In Male Sexual Dysfunction, 302–13. Chichester, UK: John Wiley & Sons, Ltd, 2016. http://dx.doi.org/10.1002/9781118746509.ch32.
Der volle Inhalt der Quelle
6
Al-Shaiji, Tariq F., Eric Chung und Gerald B. Brock. „Erectile Dysfunction: Pharmacological Therapy“. In Cancer and Sexual Health, 675–96. Totowa, NJ: Humana Press, 2011. http://dx.doi.org/10.1007/978-1-60761-916-1_44.
Der volle Inhalt der Quelle
7
Maruccia, Serena, und Angela Maurizi. „Anatomical and Physiological Description of Women’s Sexuality“. In Female Sexual Function and Dysfunction, 7–25. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-41716-5_2.
Der volle Inhalt der Quelle
8
Banner, Linda L. „Sex Therapy in Female Sexual Dysfunction“. In Cancer and Sexual Health, 649–56. Totowa, NJ: Humana Press, 2011. http://dx.doi.org/10.1007/978-1-60761-916-1_42.
Der volle Inhalt der Quelle
9
Althof, Stanley E., und Rachel B. Needle. „Sex Therapy in Male Sexual Dysfunction“. In Cancer and Sexual Health, 731–38. Totowa, NJ: Humana Press, 2011. http://dx.doi.org/10.1007/978-1-60761-916-1_48.
Der volle Inhalt der Quelle
10
Rajfer, Jacob, Nestor Gonzalez-Cadavid und Mark Jalkut. „Peyronie’s Disease: Pathophysiology and Medical Therapy“. In Atlas of Male Sexual Dysfunction, 167–81. London: Current Medicine Group, 2004. http://dx.doi.org/10.1007/978-1-4613-1087-7_11.
Der volle Inhalt der QuelleKonferenzberichte zum Thema "Sexual dysfunction, physiological – therapy"
1
Buttros, Daniel, Caroline Nakano Vitorino, Heloisa Maria de Luca Vespoli, Rafaela Caroline de Souza und Eliana Aguiar Petri Nahás. „Negative impact of adjuvant endocrine therapy on sexual function in breast cancer survivors“. In Brazilian Breast Cancer Symposium 2023. Mastology, 2023. http://dx.doi.org/10.29289/259453942023v33s1037.
Der volle Inhalt der QuelleAnnotation:
Objective: The objectives of this study were to evaluate the sexual function of postmenopausal breast cancer survivors compared with women without breast cancer and assess the impact of adjuvant breast cancer treatment on sexual function. Methodology: A cross-sectional study was conducted on 178 breast cancer survivors, stages I–III, age 45–70 years, amenorrhea for ³12 months, and sexually active, compared with 178 women with the same inclusion criteria, but without breast cancer. The groups were paired by age and menopause time, ratio 1:1. Sexual function was assessed using the Female Sexual Function Index (FSFI), consisting of six domains (desire, arousal, lubrication, orgasm, satisfaction, and pain), in which a total score ≤ 26.5 indicates sexual dysfunction. For statistical analysis, the Student’s t-test, the chi-square test, and logistic regression (odds ratio (OR)) were used. Results: Women with breast cancer had poorer sexual function in the desire domain (p=0.002). There were no significant differences between groups in the other FSFI domains and in the total score (p>0.05). Breast cancer survivors had a higher occurrence of sexual dysfunction (64.6% with a total score ≤26.5) when compared to the control group (51.6%) (p=0.010). Risk analysis adjusted for age and time since menopause showed a higher risk of sexual dysfunction in breast cancer survivors than women without cancer (OR 1.98, 95%CI 1.29– 2.96, p=0.007). Among breast cancer survivors, the use of endocrine therapy was associated with a higher risk of sexual dysfunction (OR 3.46, 95%CI 1.59–7.51, p=0.002). Conclusion: Postmenopausal breast cancer survivors had a higher risk of sexual dysfunction when compared with women without breast cancer, impacted by the use of endocrine therapy for the treatment of breast cancer.
2
Kumalasari, Ratna Dewi, idik Gunawan Tamtomo und Hanung Prasetya. „Hypnosis and Sexual Arousal: A Meta-Analysis“. In The 7th International Conference on Public Health 2020. Masters Program in Public Health, Universitas Sebelas Maret, 2020. http://dx.doi.org/10.26911/the7thicph.05.41.
Der volle Inhalt der QuelleAnnotation:
ABSTRACT Background: Marriage problems that often arise often begin with sexual problems. Sexuality is not always focused on coital activity which includes cycles of desire, excitement, orgasm, and resolution but it is also related to non coital activity. Sexual satisfaction refers to a person’s pleasant feelings of the type of sexual relationship that forms an important part of the impression of one partner with another which in turn maintains their marriage. 75 percent of all women and 50 percent of all men have experienced sexual difficulties. Sexual dysfunction occurs in almost half of marriages and in about 75 percent of couples who need therapy or assistance in marital problems. This study aimed to analyze the effect of hypnosis in patients with sexual dysfunction. Subjects and Method: This was a meta-analysis and systematic review. The articles were obtained from Pubmed, Science Direct, Springer Link, and Google Scholar electronic databases. Keywords to search articles were “non-medical therapy”, “nonmedical treatment”, “randomized control trial”, “sexual disorder”, “sexual function”, and “sexual satisfaction”. The articles studied were full text articles with observational study design. The articles were collected using PRISMA diagrams and analyzed using the Review Manager 5.3. Results: Hypnosis increased sexual arousal by 2.16 times compared to not providing the therapy (OR= 2.16; 95% CI = 1.76 to 2.56; p<0.001). Conclusion: Hypnosis increases sexual arousal. Keywords: Hypnosis, sexual arousal, meta analysis Correspondence: Ratna Dewi Kumalasari. Masters Program in Public Health, Universitas Sebelas Maret. Email: logicakinanthi@gmail.com. Mobile: (+62) 81330542623. DOI: https://doi.org/10.26911/the7thicph.05.41
3
Frechette, D., L. Paquet, S. Verma, M. Clemons, P. Wheatley-Price, SZ Gertler, X. Song, N. Graham und S. Dent. „PD04-04: Sexual Dysfunction in Women with Early Stage Breast Cancer on Endocrine Therapy: Encouraging Results from a Prospective Study.“ In Abstracts: Thirty-Fourth Annual CTRC‐AACR San Antonio Breast Cancer Symposium‐‐ Dec 6‐10, 2011; San Antonio, TX. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/0008-5472.sabcs11-pd04-04.
Der volle Inhalt der Quelle
4
Bitenc Zore, Sara, Domen Vozel und Saba Battelino. „Facial Nerve Reconstructive Surgery in Otorhinolaryngology and its Enhancement by Platelet- and Extracellular Vesicle-Rich Plasma Therapy“. In Socratic Lectures 7. University of Lubljana Press, 2022. http://dx.doi.org/10.55295/psl.2022.d5.
Der volle Inhalt der QuelleAnnotation:
The facial nerve and its reconstructive surgical procedures are complex and challenging. The main function of facial nerve is namely motor innervation of facial muscles and its dysfunction presents as facial paralysis. Depending on the extent of facial nerve injury (neurapraxia, axonotmesis, neurotmesis) and consequently a physiological phenomenon of Wallerian degeneration, mechanism, location of the injury, time course of the paralysis and medical condition we decide about the type of the reconstructive surgery. Generally, possible surgical interventions to improve facial nerve functioning are mainly nerve decompression, neurorrhaphy/end-to-end anastomosis, interposition (cable) grafts and nerve rerouting. Moreover, most commonly nerves undergoing facial reconstruction are great auricular and sural nerves. In addition, nerve rehabilitation can be improved by using platelet-rich plasma (PRP/PVRP), applied directly to nerve. There are many roles of PVRP, described in the literature such as neuroprotective, neurogenic, neuroinflammatory, angiogenic role and improving hemostasis. Also, its neoplastic and proliferative effects were not reported. Considering all these features implementing PVRP in the facial nerve regenerative treatment has strong potential in the future. Keywords: Facial nerve; Reeconstructive surgery; Platelet and extracellular vesicle rich plasma; Nerve regeneration
5
Sadeghi Bahmani, D., V. Farnia, M. Alikhani, F. Tatari, E. Holsboer-Trachsler und S. Brand. „Rosa Damascena Oil improved methadone-induced sexual dysfunction and happiness in female patients with opium use disorder under methadone maintenance therapy – results from a double-blind, randomized, and placebo-controlled trial“. In Abstracts of the 30th Symposium of the AGNP. Georg Thieme Verlag KG, 2017. http://dx.doi.org/10.1055/s-0037-1606431.
Der volle Inhalt der Quelle
6
Trivellato, Stella de Angelis, Joao Lucas Gomes Salgado, Hendrick Henrique Fernandes Gramasco, Guilherme Drumond Jardini Anastacio, Daniel Fabiano Barbosa Dos Santos, Laura Cardia Gomes Lopes und Júlio Cesar dos Santos Moreira. „Thoracolumbar progressive myelopathy due to extra-dural arteriovenous fistula“. In XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.223.
Der volle Inhalt der QuelleAnnotation:
Context: Arteriovenous dural fistulas are the most common spinal vascular malformations and constitute a reversible cause of progressive myelopathy. This disease affects elderly men and are classically found at the thoracolumbar region. Case report: A 69year-old man was admitted to the Neurology outpatient clinic with weakness in his left inferior limb for the past 10 years; 2 years before the evaluation, the weakness progressed also to the right inferior limb, causing inability to walk, and 1 year after the patient noticed urinary incontinence and sexual dysfunction. Physical evaluation showed grade-II paraparesis with spastic hypertonia; hypoesthesia below T-10 dermatome; hyperreflexia with clonus and Babinski sign in inferior limbs. Investigation with MRI showed abnormal hypersignal within spinal cord from T6-T7 to the medullary cone; CSF sample had hyper protein count without pleocytosis. Before the hypothesis of non- compressive, non-inflammatory and non-infectious myelopathy, we performed a spinal angiography – which diagnosed a dural arteriovenous fistula at the level of T8 connecting spinal with extradural vessels. The patient was then treated by endovascular therapy with fistula embolization. Conclusion: Although being the most common vascular spinal malformation, arteriovenous dural fistulas are rare and underdiagnosed because of their nonspecific symptoms. The aim of treatment is the shunt occlusion but its prognosis depends on the duration and intensity of symptoms before treatment. This report’s aim is to exemplify a typical case of this condition.
Berichte der Organisationen zum Thema "Sexual dysfunction, physiological – therapy"
1
Duan, Liyang, Xiaoyu Li, Haiqin Rong, Haiju Sun, Yajun Zhang, Shipeng Song, Jianqiao Fang und Yongqiang Sun. Scalp acupuncture for Post-stroke depression: A protocol for a systematic review and meta-analysis of randomized controlled clinical trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, April 2022. http://dx.doi.org/10.37766/inplasy2022.4.0059.
Der volle Inhalt der QuelleAnnotation:
Review question / Objective: To evaluate the efficacy and safety of scalp acupuncture for poststroke depression for the first time, and the results of this systematic review will be helpful for clinicians to use scalp acupuncture in the treatment of PSD. Condition being studied: Post-stroke depression (PSD) is one of the most common psychological sequelae of stroke, which is a state characterized by low mood and aversion to activity. It is one of the main obstacles in the process of stroke rehabilitation, which has a detrimental impact on functional recovery and quality of life and even increases mortality. Although the pathogenic factors of PSD are complex and diverse, it is now widely believed to involve complex interactions between neurobiological dysfunctions, psychosocial distress and biological factors. Despite increasing awareness and clinically based research on PSD, drugs to relieve and treat symptoms have made only limited gains. The use of antidepressants is accompanied by various unavoidable adverse effects, including headache, nausea, restlessness, and sexual dysfunction. A previous meta-analysis demonstrated that acupuncture can be safe and effective for the treatment of post-stroke depression. However, there is a lack of systematic reviews to evaluate the efficacy and safety of scalp acupuncture, which is a commonly used acupuncture modality in the treatment of PSD. Consequently, this study will assess the efficacy and safety of scalp acupuncture therapy for PSD compared to other treatments.
2
Dahm, Philipp, Michelle Brasure, Elizabeth Ester, Eric J. Linskens, Roderick MacDonald, Victoria A. Nelson, Charles Ryan et al. Therapies for Clinically Localized Prostate Cancer. Agency for Healthcare Research and Quality (AHRQ), September 2020. http://dx.doi.org/10.23970/ahrqepccer230.
Der volle Inhalt der QuelleAnnotation:
Objective. To update findings from previous Agency for Healthcare Research and Quality (AHRQ)- and American Urological Association (AUA) funded reviews evaluating therapies for clinically localized prostate cancer (CLPC). Sources. Bibliographic databases (2013–January 2020); ClinicalTrials.gov; systematic reviews Methods. Controlled studies of CLPC treatments with duration ≥5 years for mortality and metastases and ≥1 year for quality of life and harms. One investigator rated risk of bias (RoB), extracted data, and assessed certainty of evidence; a second checked accuracy. We analyzed English-language studies with low or medium RoB. We incorporated findings from randomized controlled trials (RCTs) identified in the prior reviews if new RCTs provided information on the same intervention comparison. Results. We identified 67 eligible references; 17 were unique RCTs. Among clinically rather than prostate specific antigen (PSA) detected CLPC, Watchful Waiting (WW) may increase mortality and metastases versus Radical Prostatectomy (RP) at 20+ years. Urinary and erectile dysfunction were lower with WW versus RP. WW’s effect on mortality may vary by tumor risk and age but not by race, health status, comorbidities, or PSA. Active Monitoring (AM) probably results in little to no difference in mortality in PSA detected CLPC versus RP or external beam radiation (EBR) plus Androgen Deprivation (AD) regardless of tumor risk. Metastases were slightly higher with AM. Harms were greater with RP than AM and mixed between EBR plus AD versus AM. 3D-conformal EBR and AD plus low-dose-rate brachytherapy (BT) provided a small reduction in all-cause mortality versus three dimensional conformal EBR and AD but little to no difference on metastases. EBR plus AD versus EBR alone may result in a small reduction in mortality and metastases in higher risk disease but may increase sexual harms. EBR plus neoadjuvant AD versus EBR plus concurrent AD may result in little to no difference in mortality and genitourinary toxicity. Conventionally fractionated EBR versus ultrahypofractionated EBR may result in little to no difference in mortality and metastases and urinary and bowel toxicity. Active Surveillance may result in fewer harms than photodynamic therapy and laparoscopic RP may result in more harms than robotic-assisted RP. Little information exists on other treatments. No studies assessed provider or hospital factors of RP comparative effectiveness. Conclusions. RP reduces mortality versus WW in clinically detected CLPC but causes more harms. Effectiveness may be limited to younger men or to those with intermediate risk disease and requires many years to occur. AM results in little to no mortality difference versus RP or EBR plus AD. EBR plus AD reduces mortality versus EBR alone in higher risk CLPC but may worsen sexual function. Adding low-dose-rate BT to 3D-conformal EBR and AD may reduce mortality in higher risk CLPC. RCTs in PSA-detected and MRI staged CLPC are needed.